First test of new autoimmune drug in healthy people
NCT ID NCT06827457
Summary
This was an early safety study to see how healthy adults tolerate a single injection of an experimental drug called GenSci120. Researchers tested different doses in 58 healthy volunteers in China to check for side effects and measure how the drug moves through the body. The main goal was to gather basic safety information before testing in people with autoimmune diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Huashan Hospital
Shanghai, Shanghai Municipality, 20040, China
Conditions
Explore the condition pages connected to this study.